MedTrace Logo

Art Therapy and Its Effect on Non-Motor Function Rehabilitation in the Subacute Phase of Stroke Recovery

NCT06713252 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-03

No results posted yet for this study

Summary

Stroke is one of the leading causes of disability and death worldwide, with the number of stroke patients steadily increasing due to the aging population. While traditional rehabilitation methods, such as pharmacological treatment, physical therapy, and cognitive therapy, can improve physical function to some extent, many stroke patients still face long-term non-motor impairments, including deficits in emotional, cognitive, and social functioning. Art therapy, as an integrative, non-invasive intervention, has gradually gained attention from researchers and clinicians due to its potential for restoring non-motor functions. Through artistic modalities such as music, painting, and dance, art therapy not only helps patients regulate their emotions, reducing anxiety and depression, but also promotes neuroplasticity, improving cognitive function and social participation. In the rehabilitation of stroke patients in the subacute phase, art therapy can serve as an adjunctive intervention, providing multidimensional rehabilitation support, optimizing emotional regulation and cognitive recovery, and offering new hope for the patients' overall rehabilitation.

Conditions

Interventions

BEHAVIORAL

Art therapy

Through music, painting, dance and other forms, art therapy can not only help patients regulate their emotions, relieve anxiety and depression, but also activate different areas of the brain to promote neuroplasticity, thereby promoting the recovery of motor function

BEHAVIORAL

Regular therapy

Standard treatment

Sponsors & Collaborators

  • Chonbuk National University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06713252 on ClinicalTrials.gov